Where CIRM Funding Goes
CIRM has one singular mission: Accelerating world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world.
A dedication to this mission guides every action by CIRM. With a team of dedicated staff and with oversight from its governing Board, CIRM funds promising research programs that are poised to transform stem cells into cures.
California's Stem Cell Agency was created in 2004 when 59% of California voters approved Proposition 71: the California Stem Cell Research and Cures Initiative. That initiative created the California Institute for Regenerative Medicine (CIRM) to fund stem cell research in the state. In addition to creating the agency, Prop 71 created a 29-member governing Board composed of researchers, business leaders and patient advocates. Read more about the creation of CIRM here.
Where Our Funding Goes
Proposition 71 allocated a total of $3 billion. Of that $3 billion, Prop 71 around $2.75 billion was set aside to be awarded to directly to research, facilities and training the next generation of stem cell scientists. The remainder was then earmarked for staff and administration to help oversee the funding and awards.
In 2020 voters approved Proposition 14, giving the agency an additional $5.5 billion to fund stem cell research in California.
Find Out More:
Learn about how CIRM-funded stem cell research could generate treatments for many chronic diseases and injuries.